article thumbnail

Current and novel biomarkers in cardiogenic shock

European Journal of Heart Failure

A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end-organ dysfunction.

article thumbnail

Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association

Circulation

Circulation, Ahead of Print. Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock.

article thumbnail

Survivorship After Cardiogenic Shock

Circulation

Circulation, Volume 151, Issue 3 , Page 257-271, January 21, 2025. Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%.

article thumbnail

Mixed Shock Complicating Cardiogenic Shock: A Corollary or a Ramification?

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print.

article thumbnail

Systemic Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print. The integrative physiology of the left ventricle and systemic circulation is fundamental to our understanding of advanced heart failure and cardiogenic shock. Importantly, we outline 4 key components for a more complete assessment of vascular afterload.

article thumbnail

Cardiogenic Shock Teams: Past, Present, and Future Directions

Circulation: Heart Failure

Circulation: Heart Failure, Ahead of Print. Cardiogenic shock (CS) remains a significant challenge in cardiovascular medicine, characterized by substantial morbidity and mortality. Emerging evidence indicates that structured, team-based approaches significantly improve survival rates and diminish complications linked to CS.

article thumbnail

Abstract 4146823: Trends and Outcomes in Heart Failure Admissions and Cardiogenic Shock Among Patients with Congenital Heart Disease

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients. Patients without CHD were older (mean age 71.5 years) than those with DV-CHD (mean age 59.8 years) and SV-CHD (mean age 17.9